Financials
- Market Capitalization 36.3476 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
—
ratio cours/chiffre d'affaires
—
Dividende par action
—
Rendement du dividende (%)
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4354 | CRVO CervoMed Inc. - Common Stock | 2.60 USD | -1.52% | -1.89% | +5.26% | -73.06% | 39.31 M USD | ||
| 4383 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.18 USD | -4.39% | -24.57% | -56.92% | -77.07% | 36.91 M USD | ||
| 4405 | CNTX Context Therapeutics Inc. - Common Stock | 0.38 USD | -9.52% | -22.45% | -38.71% | -55.29% | 34.91 M USD | ||
| 4410 | QNCX Quince Therapeutics, Inc. - Common Stock | 33.75 USD | +3.85% | +2.27% | +54.75% | +1970.55% | 34.33 M USD |